154 related articles for article (PubMed ID: 33848712)
1. High discordance rate in assessing sentinel node positivity in cutaneous melanoma: Expert review may reduce unjustified adjuvant treatment.
El Sharouni MA; Laeijendecker AE; Suijkerbuijk KP; Witkamp AJ; Sigurdsson V; van Diest PJ; van Gils CH; Blokx WA
Eur J Cancer; 2021 May; 149():105-113. PubMed ID: 33848712
[TBL] [Abstract][Full Text] [Related]
2. Challenges in sentinel node pathology in the era of adjuvant treatment.
Franke V; Madu MF; Bierman C; Klop WMC; van Houdt WJ; Wouters MWJM; van de Wiel BA; van Akkooi ACJ
J Surg Oncol; 2020 Oct; 122(5):964-972. PubMed ID: 32602119
[TBL] [Abstract][Full Text] [Related]
3. The difficulty with measuring the largest melanoma tumour diameter in sentinel lymph nodes.
Laeijendecker AE; El Sharouni MA; Stathonikos N; Spoto CPE; van de Wiel BA; Eijken EJE; Mulder M; Mooyaart AL; Szumera-Cieckiewicz A; Mihic-Probst D; Massi D; Cook M; Koljenovic S; Alos L; van Diest PJ; van Akkooi ACJ; Blokx W
J Clin Pathol; 2024 May; 77(6):372-377. PubMed ID: 38378246
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.
Verver D; van Klaveren D; van Akkooi ACJ; Rutkowski P; Powell BWEM; Robert C; Testori A; van Leeuwen BL; van der Veldt AAM; Keilholz U; Eggermont AMM; Verhoef C; Grünhagen DJ
Eur J Cancer; 2018 Jun; 96():25-33. PubMed ID: 29660597
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
6. Sentinel node tumor burden in prediction of prognosis in melanoma patients.
Palve J; Ylitalo L; Luukkaala T; Jernman J; Korhonen N
Clin Exp Metastasis; 2020 Apr; 37(2):365-376. PubMed ID: 32076905
[TBL] [Abstract][Full Text] [Related]
7. The sentinel node invasion level (SNIL) as a prognostic parameter in melanoma.
Kretschmer L; Mitteldorf C; Hellriegel S; Leha A; Fichtner A; Ströbel P; Schön MP; Bremmer F
Mod Pathol; 2021 Oct; 34(10):1839-1849. PubMed ID: 34131294
[TBL] [Abstract][Full Text] [Related]
8. When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'.
Gyorki DE; Barbour A; Hanikeri M; Mar V; Sandhu S; Thompson JF
Australas J Dermatol; 2017 Nov; 58(4):274-277. PubMed ID: 28718222
[TBL] [Abstract][Full Text] [Related]
9. Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas.
Baum C; Weiss C; Gebhardt C; Utikal J; Marx A; Koenen W; Géraud C
Int J Cancer; 2017 Apr; 140(8):1907-1917. PubMed ID: 27935036
[TBL] [Abstract][Full Text] [Related]
10. Sentinel node for malignant melanoma: An observational study of a consecutive single centre experience.
Belgrano V; Katsarelias D; Mattsson J; Olofsson Bagge R
Eur J Surg Oncol; 2019 Feb; 45(2):225-230. PubMed ID: 30391091
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution.
Avilés-Izquierdo JA; Nieto-Benito LM; Lázaro-Ochaita P; Escat-Cortés JL; Marquez-Rodas I; Mercader-Cidoncha E
Clin Transl Oncol; 2020 Sep; 22(9):1611-1618. PubMed ID: 32065344
[TBL] [Abstract][Full Text] [Related]
12. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma.
Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F
Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694
[TBL] [Abstract][Full Text] [Related]
13. Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging.
Gjorup CA; Woodford R; Li I; Carlino MS; Ch'ng S; Chung D; Hsiao E; Lo SN; London K; Long GV; Menzies AM; Nieweg OE; Pennington TE; Rtshiladze MA; Saw RPM; Scolyer RA; Shannon KF; Spillane AJ; Stretch JR; Thompson JF; Varey AHR; van Akkooi ACJ
Ann Surg Oncol; 2024 Mar; 31(3):1857-1864. PubMed ID: 37966706
[TBL] [Abstract][Full Text] [Related]
14. Intra-nodal nevi in sentinel node-negative patients with cutaneous melanoma does not influence survival.
de Beer FSA; van Diest PJ; Sigurdsson V; El Sharouni M
J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):2291-2295. PubMed ID: 31318994
[TBL] [Abstract][Full Text] [Related]
15. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
[TBL] [Abstract][Full Text] [Related]
16. Sentinel Lymph Node Biopsy: Past and Present Implications for the Management of Cutaneous Melanoma with Nodal Metastasis.
Gonzalez A
Am J Clin Dermatol; 2018 Nov; 19(Suppl 1):24-30. PubMed ID: 30374897
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy for cutaneous melanoma: results of 10 years' experience in two regional training hospitals in the Netherlands.
van den Broek FJ; Sloots PC; de Waard JW; Roumen RM
Int J Clin Oncol; 2013 Jun; 18(3):428-34. PubMed ID: 22402887
[TBL] [Abstract][Full Text] [Related]
18. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
[TBL] [Abstract][Full Text] [Related]
19. Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patients.
Ogata D; Tanese K; Nakamura Y; Otsuka M; Namikawa K; Funakoshi T; Yoshikawa S; Tsutsui K; Nakama K; Jinnai S; Kiyohara Y; Takahashi A; Yamazaki N
Int J Clin Oncol; 2021 Dec; 26(12):2338-2346. PubMed ID: 34545533
[TBL] [Abstract][Full Text] [Related]
20. Melanoma patient staging: histopathological versus molecular evaluation of the sentinel node.
Davids V; Kidson SH; Hanekom GS
Melanoma Res; 2003 Jun; 13(3):313-24. PubMed ID: 12777989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
